chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weakness; Dizziness; Nausea; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness), NAUSEA (Nausea), PYREXIA (Fever) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness), NAUSEA (Nausea), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness), NAUSEA (Nausea), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment medication was given for the events reported.
he is experiencing weakness of the arm; Initial information received on 22-Nov-2022 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 60 years old male patient who experienced weakness of the arm after receiving vaccine yellow fever vaccine -  [YF-VAX].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis A vaccine, Hepatitis B vaccine and influenza vaccine, all for Immunization.  On 19-Nov-2022, the patient received 0.5 milliliter (ml) dose of suspect yellow fever vaccine -  solution for injection with standard strength (lot: UJ683AA, expiry date: 15-Nov-2023) via subcutaneous route in the left arm for Immunization.  On an unknown date the patient experienced weakness of the arm (muscular weakness) (unknown latency).  It was reported that "he is experiencing weakness of the arm where the vaccine was administered. Upon further confirmation, it is not pain but weakness, "locking up and feels dead" on certain range of motion".  Action taken: not applicable.  No corrective treatment was received for the event.  Outcome: Unknown.
Immune system type reactions; Vaccine dose from 2 vials; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Vaccine dose from 2 vials) and IMMUNE-MEDIATED ADVERSE REACTION (Immune system type reactions) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 30-Dec-2020, the patient experienced PRODUCT ADMINISTRATION ERROR (Vaccine dose from 2 vials). On 28-Jan-2021, the patient experienced IMMUNE-MEDIATED ADVERSE REACTION (Immune system type reactions). On 28-Jan-2021, PRODUCT ADMINISTRATION ERROR (Vaccine dose from 2 vials) had resolved. At the time of the report, IMMUNE-MEDIATED ADVERSE REACTION (Immune system type reactions) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  Treatment information was not provided.   This case was linked to MOD-2021-028537 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: No new information received. On 18-Mar-2021: Follow-up information included patient's age, gender and date of birth changed, dose and unit.
VERY flu-like 20 hours following shot. Severe headache, aches, chills, hot (no fever), nausea (dry-heaving), fatigue
Arm still sore; Shoulder still sore; Soreness at the injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number NY749, expiry date 4th December 2021) for prophylaxis.   On 26th September 2019, the patient received the 1st dose of Shingrix .5 ml. On 27th September 2019, 1 days after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the patient experienced pain in arm and shoulder pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved and the outcome of the pain in arm and shoulder pain were unknown.   It was unknown if the reporter considered the injection site pain, pain in arm and shoulder pain to be related to Shingrix.  Additional details were provided as follows: The patient reported soreness at the injection a day following the administration. The patient arm and shoulder are still sore. The reporter consented to follow up.
Alot of headache  Moment of cold  Feel dizziness when stand  Pain does not stop Thirsty  Weak body
extremely tired; This case was reported by a consumer and described the occurrence of tiredness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On 27th February 2021, less than a week after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was not recovered/not resolved.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details provided as follow: Age at vaccination  and gender of the patient is not reported. The patiient asked how long does the side effects last. It has been 2 and half days since 2nd shot and was still extremely tired. No other adverse event was reported. No further information available.
rash on face devel w/in 3-4 hr p/vax yellow pus-T103 p/APAP;temp lasted x 3 days on ATB cream to face then oral ATB;c/o sore throat & diff talking;
significant body aches at night, 24 hours later headache,chills, fatigue, temp of 99.5, 48 hours later fatigued in general not well-being, chills, fatigue, injection site pain, malaise new or worsened join and muscle pain
Pt reports that upon administration of Shingrix shot in Left Arm he experienced sharp pain. He felt sick for 2 days and the injection site was swollen and red. This much was normal. However, the swelling continued and his entire left arm for the past 2 weeks has been swollen without resolution and tender to the touch. He had not told the pharmacy staff of his previous lymph node removal in the left arm and side and has never had an issue after an immunization there. He has been evaluated by Dr who had him get a series of MRI's for which he is awaiting the results.
Acute onset of pruritis, red blotchy skin especially over (L) arm. Some on neck, head, skin folds of upper and lower extremity. Also c/o "feeling a knot on throat". Tx: BENADRYL 50 mg IM (R) deltoid, O2 at GLT/min x 15 min., Topical HCT 1% cream, cold pack, bed rest.
Very sore upper arms .  Right upper arm aches all the time and I can't lift or hold much weight.  I am afraid to get the booster shot because it may make my arms weaker and more painful.
This is a spontaneous report from a contactable physician reported via a Pfizer sales representative. This physician reported similar events for six patients. This is the first of six reports. A child (age and gender unknown) received a dose of PREVNAR 13 on an unknown date. Relevant medical history and concomitant medications were not provided. On an unspecified date approximately five to six days after vaccination, the patient had large, raised, dark red swelling about 4 inches in diameter at the vaccination site and fever. Outcome was unknown. Follow-up (04Aug2011): Follow-up attempts completed. No further information expected.
Immediately after receiving sore in left shoulder, patient developed lateral shoulder pain, which was worse with lifting arm.  Pain has persisted since then, which has not responded to conservative measures.  She was found to have small high-grade partial thickness of her anterior distal supraspinatus tendon tear.
Legs cramps and muscle spasms/horrible legs cramps in the right leg/very, very intense/real intense/weren't constant, was like a contraction; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN9581; Expiration Date: May2021), via an unspecified route of administration, administered in Arm Right on 10Feb2021 11:00 (at the age of 73-year-old) as dose 1, single for covid-19 immunisation. Medical history included diabetes mellitus from an unknown date and unknown if ongoing Verbatim: Diabetes, factor v leiden carrier from an unknown date and unknown if ongoing All family has factor 5 blood from her mother's side of the family. Her grandchildren's parents both have factor 5 blood, lower limb fracture from an unknown date and unknown if ongoing, broke her right leg and was down for 9 weeks. Developed a huge blood clot and was hospitalized last year. Had a pulmonary embolism. Confirmed this was prior to the COVID-19 Vaccine, suspected covid-19 from an unknown date and unknown if ongoing Was COVID positive in Sep2020. Was on antibiotics, oxygen, and quarantined. Ran a temperature for one day and had a headache for one day, pregnancy from an unknown date and unknown if ongoing  Had leg cramps when she was pregnant and maybe once a year, muscle spasms from an unknown date and unknown if ongoing, Had leg cramps when she was pregnant and maybe once a year, thrombosis from an unknown date and unknown if ongoing. Concomitant medications included insulin taken for diabetes mellitus, start and stop date were not reported; metformin taken for diabetes mellitus, start and stop date were not reported; rivaroxaban (XARELTO) taken for factor v leiden carrier, thrombosis, start and stop date were not reported; vitamins. The patient did not receive any other vaccines within four weeks prior to the vaccination. No adverse events following prior vaccinations. On 11Feb2021 05:00, patient experienced leg cramps and muscle spasms which weren't constant, was like a contraction. Would stop and go. At 5AM was real intense. Was real intense at 8AM. She pushed her heel out to calm it down. Ever since she got up and moving around she hasn't had it. Patient stated that she was wondering if it could be a side effect of the COVID-19 Vaccine. The patient underwent lab tests and procedures which included body temperature: ran a temperature for one day on Sep2020. The events did not require a visit. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
Fever 100.4 with Tylenol and not "feeling well". Tachycardia
Sense of restlessness requiring exercise to relieve it.  Akathisia? Intermittent started approx 3 months after 2nd dose and increased over the next two months.  Now much improved.  Note: I have low suspicion that this is related to vaccination, given the time course.  However, the folks at V-Safe asked me to report in VAERS.
Following the shot I had "normal" side effects. Tired, headache, foggy/light headed. These began about an hour after the shot and continued. 48 hours after the shot, Monday morning, I began having stomach pains and diarrhea. I continued to feel light headed and foggy. The stomach pains and diarrhea are still present today, Thursday, 04/15/21, nearly 5 days after receiving the vaccination.
I have them for quite a while, I had the shot both of them/suspected vaccination failure; I have them for quite a while; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the shingles and having for quite a while and had the Shingles shot both of them. The follow up would not be possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
PATIENT IS 16 YEARS OLD AND RECEIVED A VACCINE APPROVED FOR 18+ YEARS OLD
Mother called office 4-5 12 stating arm had red, hard lump > silver dollar at inj site. 4-6-12 Pt. developed temp 102 with chills, aches & pain. Seen in office 4-7-12 - arm felt better swelling 8x12 cm noted - Temp 97.6 no wheezing noted.
Information has been received from a physician's assistant concerning a female who was vaccinated with a second dose of Gardasil. Subsequently the patient fainted in the office. Subsequently, the patient recovered. Additional information is not expected.
Injection site red, swollen, hard for 2 weeks. Intermittent fevers 99-100.4 - treated with TYLENOL. Red rash after 1 week with cropping vesicles; approx. #30 in diaper area. Symptomatic treatment including CALAMINE lotion, BENADRYL & antibiotic ointment to 1 possible infection lesion.
Flu; Initial information was received on 09-Oct-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional via social media.  This case involves a patient (age and gender unspecified) who experienced flu (influenza), after patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, family history and concomitant medication were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Additionally, it was reported by reporter that, patient will never get the shot again and haven't had the flu.   Details of laboratory data not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported.  There will be no information available on the batch number for this case.
hip replacement; can hardly walk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TYLENOL. The following information was reported: HIP ARTHROPLASTY (medically significant), outcome "unknown", described as "hip replacement"; GAIT DISTURBANCE (medically significant), outcome "unknown", described as "can hardly walk". Additional information: Patient asked if she can take TYLENOL prior to getting the Pfizer Covid vaccine. She needed a hip replacement and can hardly walk. This will be her second shot. She was told last time when she went to get the shot that she was not able to get the first dose because she took TYLENOL and then went somewhere else so she could get the shot.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever of 101.2 F., chills, headache, and nausea for 36 hours. Symptoms began about 12 hours after taking the shot.
super mild bell's palsy; eye twitching; jaw pain; This spontaneous case was reported by a pharmacist and describes the occurrence of FACIAL PARALYSIS (super mild bell's palsy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).  On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN JAW (jaw pain). On an unknown date, the patient experienced FACIAL PARALYSIS (super mild bell's palsy) (seriousness criterion medically significant) and BLEPHAROSPASM (eye twitching). At the time of the report, FACIAL PARALYSIS (super mild bell's palsy) outcome was unknown and PAIN IN JAW (jaw pain) and BLEPHAROSPASM (eye twitching) had not resolved. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  Patient experienced super mild case of Bell's palsy. Within an hour of receiving the injection he developed jaw pain. There was no dropping of the jaw. He still has residual jaw pain and some eye twitching. He is scheduled for his second injection and would like to know if the reaction to the second dose could be worse. Also, would like to know if he should administer the injection in the opposite arm. No treatment information was provided.; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Adverse Event: Red itchy rash on multiple locations on the body.  Mostly on the large areas of left, front and right torso and back.  Also smaller selected areas on arms and legs. Treatment: Applied OTC topical 1% Hydrocortisone cream to all affected areas to control itching.  Bathed twice/day to clean area and reapply topical cream.  After second day started taking 24 hour allergy pills (active ingredients 10 mg Loratadine [antihistamine]).  Never consulted with a doctor. Outcomes: After taking antihistamine and continued topical treatment, rash started improving (reduced redness and itching). After 6 days of treatment, itchiness nearly gone, rash still is apparent at all sites,  progressing towards normal color.
One day post vax pt experienced a fever up to 100.7.  The next day fever up to 103.7.  4 cm diameter area of redness, swelling and some induration at site of injection - right thigh. Pt was exposed to a child with a fever.  Pt diagnosed with pharyngitis.
Fever, headache, generalized "achiness" for 36 hrs post vaccine beginning on 3/11/2021. Caller states that last night while walking, he experienced "bone pain" in left leg, foot began dragging and leg numbness from knee down. Denies any pain, reports that he was able to walk home. Caller states that he went home and went to sleep, woke up 1.5 hrs later and symptoms had resolved. No other symptoms. Advised to contact PCP. Also advised of s/s of needing emergent care, such as SOB, chest pain, and/or neuro changes
Patient triceps area got swollen, redness, rashes and very painful. Recommended: Take Ibuprofen, diphenhydramine and iced the affected area. Also need to follow up with urgent care.
This spontaneous report as received from a medical assistant (other health professional) refers to unspecified number of patients of unknown age. Pertinent medical histories and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored ROTATEQ, 1 DF orally for prophylaxis (incorrect product storage). Temperature excursion 32 to 35 degree Fahrenheit for 5 minutes and 47 to 77 Fahrenheit for 17 minutes. No adverse reactions (no adverse event) per primary reporter. NO further information to report. This is one of the several reports from same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1706USA001928: Original Case : 1706USA001387 US-009507513-1706USA001929: Original Case : 1706USA001387 US-009507513-1706USA001387: Original Case : 1706USA001387.
Large rash near site of injection. Started out like large welts, then became one large red welt the size of my hand. Looked like a bad sunburn. Was hot to the touch, and itchy. Treated with hydrocortisone cream and Benadryl. Rash began to subside after three days, and was lightly visible still two weeks later.
Sudden sensorineural hearing loss in right ear, severe with 50-70 db loss
Information has been received from a physician concerning a 12 year old female with no pertinent medical history, who in 1998 was vaccinated SC with a first, one time 0.5 ml dose of Varivax. There was no concomitant medication. ON approximately 20-OCT-2006 the patient developed chickenpox and on 25-OCT-2006 the patient presented to the office "covered head to toe with chickenpox". Unspecified medical attention was sought and "blood work" was performed (results not reported). At the time of the report the patient was recovering. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Patients received vaccine with silver metal particles; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients received vaccine with silver metal particles) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received vaccine with silver metal particles). On 30-Nov-2021, POOR QUALITY PRODUCT ADMINISTERED (Patients received vaccine with silver metal particles) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment information was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2021: follow-up received contains (batch no.) from updated narrative.
This spontaneous report has been received from a licensed practical nurse referring to a patient of unknown age and gender. No current or historical conditions were reported. On 17-MAY-2016 the patient was vaccinated with PEDVAXHIB (lot # L051122, expired date of 12-OCT-2018, dose and route unknown) and ROTATEQ (Lot # L028645, expired date of 25-MAY-2017, oral and dose unknown). The vaccines were improperly stored under 9.1 Celsius degree for 30 minutes. No previous temperature excursion. Data logger was involved. No adverse effects was reported. This is one of several reports received from the same reporter. Additional information has been requested.
9/14/12 Rash, swelling on (L) arm, c/o of chills and body aches. Temp - 98.4 F on visit.
About 1 hour after the shot the child broke out in petiachiae all over. Spoke to Peds ID. He had never heard of petichiae about 1 hour after a shot. Child sent to ER; got washed out for petiachiae. Was diagnosed for rash; resolved.